Table of Contents Chapter 1 Overview of Tissue Sealants 1.1 Definition of Tissue Sealants in This Report 1.2 Commercial Types of Tissue Sealants 1.2.1 Fibrin 1.2.2 Synthetic Sealant 1.3 Downstream Application of Tissue Sealants 1.3.1 Hospitals 1.3.2 Research Institutions 1.4 Development History of Tissue Sealants 1.5 Market Status and Trend of Tissue Sealants 2013-2023 1.5.1 EMEA Tissue Sealants Market Status and Trend 2013-2023 1.5.2 Regional Tissue Sealants Market Status and Trend 2013-2023 Chapter 2 EMEA Market Status and Forecast by Regions 2.1 Market Status of Tissue Sealants in EMEA 2013-2017 2.2 Consumption Market of Tissue Sealants in EMEA by Regions 2.2.1 Consumption Volume of Tissue Sealants in EMEA by Regions 2.2.2 Revenue of Tissue Sealants in EMEA by Regions 2.3 Market Analysis of Tissue Sealants in EMEA by Regions 2.3.1 Market Analysis of Tissue Sealants in Europe 2013-2017 2.3.2 Market Analysis of Tissue Sealants in Middle East 2013-2017 2.3.3 Market Analysis of Tissue Sealants in Africa 2013-2017 2.4 Market Development Forecast of Tissue Sealants in EMEA 2018-2023 2.4.1 Market Development Forecast of Tissue Sealants in EMEA 2018-2023 2.4.2 Market Development Forecast of Tissue Sealants by Regions 2018-2023 Chapter 3 EMEA Market Status and Forecast by Types 3.1 Whole EMEA Market Status by Types 3.1.1 Consumption Volume of Tissue Sealants in EMEA by Types 3.1.2 Revenue of Tissue Sealants in EMEA by Types 3.2 EMEA Market Status by Types in Major Countries 3.2.1 Market Status by Types in Europe 3.2.2 Market Status by Types in Middle East 3.2.3 Market Status by Types in Africa 3.3 Market Forecast of Tissue Sealants in EMEA by Types Chapter 4 EMEA Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Tissue Sealants in EMEA by Downstream Industry 4.2 Demand Volume of Tissue Sealants by Downstream Industry in Major Countries 4.2.1 Demand Volume of Tissue Sealants by Downstream Industry in Europe 4.2.2 Demand Volume of Tissue Sealants by Downstream Industry in Middle East 4.2.3 Demand Volume of Tissue Sealants by Downstream Industry in Africa 4.3 Market Forecast of Tissue Sealants in EMEA by Downstream Industry Chapter 5 Market Driving Factor Analysis of Tissue Sealants 5.1 EMEA Economy Situation and Trend Overview 5.2 Tissue Sealants Downstream Industry Situation and Trend Overview Chapter 6 Tissue Sealants Market Competition Status by Major Players in EMEA 6.1 Sales Volume of Tissue Sealants in EMEA by Major Players 6.2 Revenue of Tissue Sealants in EMEA by Major Players 6.3 Basic Information of Tissue Sealants by Major Players 6.3.1 Headquarters Location and Established Time of Tissue Sealants Major Players 6.3.2 Employees and Revenue Level of Tissue Sealants Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Tissue Sealants Major Manufacturers Introduction and Market Data 7.1 Advanced Medical Solutions Group 7.1.1 Company profile 7.1.2 Representative Tissue Sealants Product 7.1.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Advanced Medical Solutions Group 7.2 Baxter International 7.2.1 Company profile 7.2.2 Representative Tissue Sealants Product 7.2.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Baxter International 7.3 C. R. Bard 7.3.1 Company profile 7.3.2 Representative Tissue Sealants Product 7.3.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of C. R. Bard 7.4 Cryolife 7.4.1 Company profile 7.4.2 Representative Tissue Sealants Product 7.4.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Cryolife 7.5 CSL Behring 7.5.1 Company profile 7.5.2 Representative Tissue Sealants Product 7.5.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of CSL Behring 7.6 Integra LifeSciences 7.6.1 Company profile 7.6.2 Representative Tissue Sealants Product 7.6.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Integra LifeSciences 7.7 Johnson & Johnson 7.7.1 Company profile 7.7.2 Representative Tissue Sealants Product 7.7.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Johnson & Johnson 7.8 B. Braun 7.8.1 Company profile 7.8.2 Representative Tissue Sealants Product 7.8.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of B. Braun 7.9 Cardinal Health 7.9.1 Company profile 7.9.2 Representative Tissue Sealants Product 7.9.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Cardinal Health 7.10 Cohera Medical 7.10.1 Company profile 7.10.2 Representative Tissue Sealants Product 7.10.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Cohera Medical 7.11 Haemacure 7.11.1 Company profile 7.11.2 Representative Tissue Sealants Product 7.11.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Haemacure 7.12 HyperBranch Medical Technology 7.12.1 Company profile 7.12.2 Representative Tissue Sealants Product 7.12.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of HyperBranch Medical Technology 7.13 NeoMend 7.13.1 Company profile 7.13.2 Representative Tissue Sealants Product 7.13.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of NeoMend 7.14 Smith & Nephew 7.14.1 Company profile 7.14.2 Representative Tissue Sealants Product 7.14.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Smith & Nephew 7.15 Teijin Pharma 7.15.1 Company profile 7.15.2 Representative Tissue Sealants Product 7.15.3 Tissue Sealants Sales, Revenue, Price and Gross Margin of Teijin Pharma 7.16 Tissuemed 7.17 Vascular Solutions 7.18 Vivostat 7.19 Z-Medica Chapter 8 Upstream and Downstream Market Analysis of Tissue Sealants 8.1 Industry Chain of Tissue Sealants 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Tissue Sealants 9.1 Cost Structure Analysis of Tissue Sealants 9.2 Raw Materials Cost Analysis of Tissue Sealants 9.3 Labor Cost Analysis of Tissue Sealants 9.4 Manufacturing Expenses Analysis of Tissue Sealants Chapter 10 Marketing Status Analysis of Tissue Sealants 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Fibrin Table Advantage and Disadvantage of Synthetic Sealant Table Consumption Volume of Tissue Sealants in EMEA by Regions 2013-2017 Table Revenue of Tissue Sealants in EMEA by Regions 2013-2017 Table Consumption Volume of Tissue Sealants in EMEA by Regions 2018-2023 Table Revenue of Tissue Sealants in EMEA by Regions 2018-2023 Table Consumption Volume of Tissue Sealants in EMEA by Types 2013-2017 Table Revenue of Tissue Sealants in EMEA by Types 2013-2017 Table Consumption Volume of Tissue Sealants by Types in Europe 2013-2017 Table Consumption Volume of Tissue Sealants by Types in Middle East 2013-2017 Table Consumption Volume of Tissue Sealants by Types in Africa 2013-2017 Table Consumption Volume Forecast of Tissue Sealants in EMEA by Types 2018-2023 Table Revenue Forecast of Tissue Sealants in EMEA by Types 2018-2023 Table Demand Volume of Tissue Sealants in EMEA by Downstream Industry 2013-2017 Table Demand Volume of Tissue Sealants by Downstream Industry in Europe 2013-2017 Table Demand Volume of Tissue Sealants by Downstream Industry in Middle East 2013-2017 Table Demand Volume of Tissue Sealants by Downstream Industry in Africa 2013-2017 Table Demand Volume Forecast of Tissue Sealants in EMEA by Downstream Industry 2018-2023 Table Sales Volume of Tissue Sealants in EMEA by Major Players 2013-2017 Table Revenue of Tissue Sealants in EMEA by Major Players 2013-2017 Table Headquarters Location and Established Time of Tissue Sealants Major Players Table Employees and Revenue Level of Tissue Sealants Major Players Table Representative Tissue Sealants Product One of Advanced Medical Solutions Group Table Representative Tissue Sealants Product Two of Advanced Medical Solutions Group Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Advanced Medical Solutions Group 2013-2017 Table Representative Tissue Sealants Product One of Baxter International Table Representative Tissue Sealants Product Two of Baxter International Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Baxter International 2013-2017 Table Representative Tissue Sealants Product One of C. R. Bard Table Representative Tissue Sealants Product Two of C. R. Bard Table Tissue Sealants Sales, Revenue, Price and Gross Margin of C. R. Bard 2013-2017 Table Representative Tissue Sealants Product One of Cryolife Table Representative Tissue Sealants Product Two of Cryolife Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Cryolife 2013-2017 Table Representative Tissue Sealants Product One of CSL Behring Table Representative Tissue Sealants Product Two of CSL Behring Table Tissue Sealants Sales, Revenue, Price and Gross Margin of CSL Behring 2013-2017 Table Representative Tissue Sealants Product One of Integra LifeSciences Table Representative Tissue Sealants Product Two of Integra LifeSciences Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Integra LifeSciences 2013-2017 Table Representative Tissue Sealants Product One of Johnson & Johnson Table Representative Tissue Sealants Product Two of Johnson & Johnson Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2013-2017 Table Representative Tissue Sealants Product One of B. Braun Table Representative Tissue Sealants Product Two of B. Braun Table Tissue Sealants Sales, Revenue, Price and Gross Margin of B. Braun 2013-2017 Table Representative Tissue Sealants Product One of Cardinal Health Table Representative Tissue Sealants Product Two of Cardinal Health Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Cardinal Health 2013-2017 Table Representative Tissue Sealants Product One of Cohera Medical Table Representative Tissue Sealants Product Two of Cohera Medical Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Cohera Medical 2013-2017 Table Representative Tissue Sealants Product One of Haemacure Table Representative Tissue Sealants Product Two of Haemacure Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Haemacure 2013-2017 Table Representative Tissue Sealants Product One of HyperBranch Medical Technology Table Representative Tissue Sealants Product Two of HyperBranch Medical Technology Table Tissue Sealants Sales, Revenue, Price and Gross Margin of HyperBranch Medical Technology 2013-2017 Table Representative Tissue Sealants Product One of NeoMend Table Representative Tissue Sealants Product Two of NeoMend Table Tissue Sealants Sales, Revenue, Price and Gross Margin of NeoMend 2013-2017 Table Representative Tissue Sealants Product One of Smith & Nephew Table Representative Tissue Sealants Product Two of Smith & Nephew Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Smith & Nephew 2013-2017 Table Representative Tissue Sealants Product One of Teijin Pharma Table Representative Tissue Sealants Product Two of Teijin Pharma Table Tissue Sealants Sales, Revenue, Price and Gross Margin of Teijin Pharma 2013-2017